Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SMALL-CAP WINNERS & LOSERS: EnQuest falls on production output warning

Thu, 02nd Sep 2021 10:55

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

----------

SMALL-CAP - WINNERS

----------

Tiziana Life Sciences PLC, up 18% at 72.35 pence, 12-month range 46.44p-206.00p. The clinical stage biotechnology company alongside US peer Precision BioSciences announce an exclusive license agreement to evaluate Tiziana's Foralumab, an anti-CD3 monoclonal antibody in conjunction with allogeneic CAR T candidates for cancer treatment. The companies would explore Foralumab as an agent to induce tolerance of allogeneic CAR T cells to potentially improve the clinical outcome of CAR T cell therapy. Under the terms, Tiziana will receive upfront payment, certain milestone payments, and royalties for Foralumab.

----------

Gym Group PLC, up 3.4% at 292.58 pence, 12-month range 116.00p-317.50p. The no-frills gym chain reports rise in membership as restrictions ease. For the six months ended June 30, pretax loss barely narrows to GBP28.5 million from GBP28.6 million the year before, as administrations costs remain high at GBP54.6 million, and revenue declines 21% to GBP29.3 million from GBP37.3 million. However, membership numbers at the end of June rose to 730,000 from 698,000 a year prior. Looking ahead, membership numbers at the end of August dipped to 721,000 from June, but sees higher membership levels in September and October as students return to universities. "Despite the significant disruption caused by the pandemic, Gym Group is well placed to continue its steady recovery and plans for growth as it capitalises on a return to more normal activity," says Edison analyst Richard Finch.

----------

SMALL-CAP - LOSERS

----------

EnQuest, down 7.7% at 23.30p, 12-month range 8.67p-26.95p. The oil and gas firm reports narrowed first half loss, but warns full-year production will be at the lower end of the guidance range. For six months to June 30, its profit after tax narrowed to USD56.4 million from a USD472.4 million loss last year. Looking ahead, EnQuest sees 2021 average net production at the lower end of the guidance range of 46,000 barrels of oil equivalent per day and 52,000 boepd. This reflects expected performances at Magnus, the Greater Kittiwake Area and PM8/Seligi over the course of the second half of the year, it says.

----------

SDCL Energy Efficiency Income Trust PLC, down 3.7% at 113.17p, 12-month range 104.50p-119.00p. The investment company intends to raise GBP175 million via a share issue at 110.50p each, which is 6.0% discount to Wednesday's closing share price of 117.50p.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Jul 2016 08:46

Tiziana Life Buys Gene Samples Of Long-Lifed Sardinian Community

Read more
24 Jun 2016 09:49

WINNERS & LOSERS SUMMARY: Gold, Dollar Exposure Rewarded Post-Brexit

Read more
24 Jun 2016 07:44

UPDATE: UK Chemicals And Pharmaceuticals Must "Look To Future"

Read more
23 Jun 2016 15:08

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jun 2016 08:27

Tiziana Life Sciences 2015 Loss Widens As It Progresses Candidates

Read more
1 Jun 2016 14:49

Tiziana partnership scoops innovation award

(ShareCast News) - Clinical stage biotechnology company Tiziana Life Sciences was celebrating on Wednesday, after its partnership with researchers at Cardiff University collected a fresh award. The AIM-traded company said the partnership, which has led to the development of a potential new drug for

Read more
19 May 2016 10:13

Tiziana Life Sciences Says Its Antibody Foralumab Featured In Review

Read more
4 Apr 2016 07:36

Tiziana Life Sciences Appoints Tiziano Lazzaretti As Finance Chief

Read more
4 Apr 2016 07:32

Tiziana Life Sciences appoints new CFO

(ShareCast News) - Tiziana Life Sciences has appointed Tiziano Lazzaretti as Chief Financial Officer, effective immediately. Confirming the move on Monday, the AIM-listed biotechnology company said the appointment was not a board level position. Lazzaretti has extensive experience in the healthcare

Read more
13 Jan 2016 09:53

Tiziana Life Sciences Raises Funds Via Convertible Loan Note Issue (ALLISS)

Read more
11 Jan 2016 09:17

Tiziana To Focus Foralumab Development On Two Clinical Applications

Read more
8 Jan 2016 08:35

Tiziana reveals possible new anti-cancer molecule

(ShareCast News) - Tiziana Life Sciences revealed the great strides it had made in the quest for cancer-fighting drugs this week, as part of its research partnership with the Cardiff University / Prifysgol Caerdydd. The AIM-listed biotechnology company, which focuses on targeted drugs to treat disea

Read more
8 Jan 2016 07:54

Tiziana Identifies New Potential Cancer Drug With Cardiff University

Read more
9 Dec 2015 09:20

Tiziana Life Sciences Appoints James Tripp Chief Operating Officer

Read more
8 Dec 2015 10:04

Tiziana Life Sciences Raises GBP3.8 Million Via Convertible Note Issue (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.